In a Phase 2/3 clinical trial, the Pfizer-BioNTech COVID-19 Vaccine elicited a strong immune response in this age group Three 3-µg doses had favorable safety […]
With pediatric COVID-19 cases surpassing 10 million and at the request of the FDA, the companies have submitted available data on the safety and efficacy […]
…to enable rapid differentiation of viral respiratory infections The combination rapid antigen test quickly differentiates between SARS-CoV-2 and influenza viruses A and B infections, with […]
Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the […]
CI-FER® reduces pathogen biofilms leading to improved zootechnical performance CI-FER® [iron (III) citrate chelate] for piglets is Akeso’s first product for the EU market based on […]
We are very pleased to announce that Tada Medical has recently raised an investment in the form of a €700,000 convertible loan from the European […]
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the initiation of a Biologics License Application (BLA) with the U.S. Food and Drug […]
Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY® PDF Version European Union exercises option under previous agreement to […]
BioNTech SE today announced that the European Medicines Agency (EMA) approved the manufacturing of the COVID-19 vaccine drug product at the facility in Marburg. As part […]
New stability data show vaccine can be stored at -25°C to -15°C for a total of two weeks and support decentralized distribution plans for vaccination […]
The European Union has announced today an additional €500 million for the COVAX Facility, doubling its contribution to date for the global initiative that is […]
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced an agreement with the European Commission (EC) to supply an additional 200 million doses […]
Copyright © 2022 | WordPress Theme by MH Themes
